Navigation Links
Sea urchin genome suprisingly similar to man and may hold key to cures

Sea urchins are small and spiny, they have no eyes and they eat kelp and algae. Still, the sea creature’s genome is remarkably similar to humans?and may hold the key to preventing and curing several human diseases, according to a University of Central Florida researcher and several colleagues.

UCF Professor Cristina Calestani was part of the Sea Urchin Genome Sequencing Group, which recently completed sequencing of the sea urchin genome and published its findings in the November issue of Science. The National Institutes of Health funded most of the nine-month project.

The genome of the purple sea urchin is composed by 814 "letters" coding for 23,300 genes.

Sea urchins are echinoderms, marine animals that originated more than 540 million years ago. The reason for the great interest in sequencing the sea urchin genome is because it shares a common ancestor with humans. Sea urchins are closer to human and vertebrates from an evolutionary perspective than other more widely studied animal models, such as fruit fly or worms. The purple sea urchin, in fact, has 7,000 genes in common with humans, including genes associated with Parkinson’s, Alzheimer’s and Huntington’s diseases and muscular dystrophy.

"Another surprise is that this spiny creature with no eyes, nose or hears has genes involved in vision, hearing and smell in humans," Calestani said. "The comparison of human genes with their corresponding ancestral sea urchin genes may give important insight on their function in humans, in the same way the study of history helps understanding the reality of our modern world."

The genome sequencing project was led by Erica Sodergren and George Weinstock at the Baylor College of Medicine-Human Genome Sequencing Center in Houston, along with Dr. Richard Gibbs, director of the Baylor center, and Drs. Eric Davidson and Andrew Cameron at the California Institute of Technology.

Of particular interest to Calestani is the way t
'"/>

Source:University of Central Florida


Page: 1 2 3

Related biology news :

1. Man and mouse share genome structures
2. Whole genome fine map of rice completed
3. Study finds more than one-third of human genome regulated by RNA
4. A bacterial genome reveals new targets to combat infectious disease
5. Scientists decipher genome of fungus that can cause life-threatening infections
6. Highly adaptable genome in gut bacterium key to intestinal health
7. Fleshing out the genome
8. Agilent Technologies new genome analysis technology set to accelerate Australia fight against mesothelioma
9. wFleaBase: the Daphnia genome database
10. NHGRI targets 12 more organisms for genome sequencing
11. Chimp genome reveals a retroviral invasion

Post Your Comments:
(Date:11/6/2009)...lebrate the 150th anniversary this month of the pu...n Institute of Biological Sciences (AIBS) is publi... Charles Darwin and his historic insights into evo... the University of California, Berkeley, and James... article, "Ten Myths About Charles Darwin," appear...
(Date:11/6/2009)...ETROIT, Nov. 6 Auburn Hills, MI-ba...) will be installing its locker system and patent-... at the U.S. Department of Health and Human Servic...ethesda, MD. The locker system will support the N...rotecting our nation,s medical research agency. T...
(Date:11/5/2009)...ational Association of Biology Teachers (NABT) wil...logical sciences at Naugatuck Valley Community Col...09 Evolution Education Award during the NABT annua...1-14 November 2009 in Denver, Colorado. , The Ev...ican Institute of Biological Sciences,(AIBS) and ...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2HPV Tied to Rare Head and Neck Cancer 59233 1HPV Tied to Rare Head and Neck Cancer 59233 2Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 1Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 2Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 3DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 1DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 2DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 3
...he Attendees, Choice Awards, NEW YORK, Dec. 5 Th...xposition (NECE) at Caesars Palace, Las Vegas, Nov...nomics decision makers and,ergonomics product sell...resenting all of the 50 states and a dozen foreign...GE, GM, Johnson & Johnson, Kaiser,Permanente, Lock...
...he University of Bonn and the University of Pittsb...o cardiac tissue of mice that had suffered heart a...thmias, thereby avoiding one of the most dangerous...covery, reported in this week,s issue of Nature, h... therapies to restore damaged heart tissue., The r...
...onal Academies have studied the health effects of ...omic bombs dropped on Hiroshima and Nagasaki, Japa...sion (ABCC), the study group was reorganized in 19...on (RERF), which is now a cooperative Japan-U.S. r...tributions of former and current ABCC/RERF employe...
Other Biology News:Record Attendance at the 2007 National Ergonomics Conference and Exposition 2Implanting embryonic cardiac cells prevents arrhythmias 2Atomic bomb survivor, scientists mark 60 years of long-term radiation study 2
(Date:11/5/2009)... CORDOVA, Calif., Nov. 5 ...upplier of innovative products for processing and ...or the first quarter of fiscal 2010. ,, For the...orted revenues of $5.2 million, a 15 percent incre...rter a year ago. The Company said the key contribu...
(Date:11/5/2009)...OK, N.Y., Nov. 5 BioSpec...armaceutical company developing first-in-class col...cial results for the third quarter ended September...n September of this year, the FDA,s Arthritis Advi...of 12-0, the approval of XIAFLEX(TM) for the treat...
(Date:11/5/2009)...EGO, CA, November 5, 2009 /PRNewswire-FirstCall/ -...d on using proprietary taste receptor-based techno...e food, beverage, and ingredient supply industries...inancial results for the third quarter ended Septe... third quarter of 2009, compared to $4.0 million f...
(Date:11/5/2009)...YMOUTH MEETING, Pa., Nov. 5 /PRNewswire-Asia-First... ("BMP Sunstone" or the "Company") today announced...009 financial results on,Monday, November 9, 2009,...ill hold a conference call at 5:00 pm ET on Novemb... Listeners may access the call by,dialing 1-888-71...
Breaking Biology Technology:ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...Oct. 10 AstraZeneca (NYSE:,AZN) today announced t...s,approved once-daily SEROQUEL XR(R) (quetiapine f...eatment of the depressive episodes associated with...sociated with bipolar I,disorder, and the maintena...therapy to lithium or divalproex. SEROQUEL XR is t...
... 10 Takeda Pharmaceutical Company,Limited ("Taked...d,Development Center, Inc., a wholly owned United ...t the U.S. Food and Drug Administration (FDA) will...tin New Drug Application,(NDA) by the Prescription...., "In our most recent discussion with the FDA, i...
...No. 2 in ranking; up six spots from last year, ST...arning recognition as a leader in biotechnology no...or being a great place to work., Monsanto, headqu...in,the 2008 Top Biotech and Pharma Employers list ...mpany moved up six spots from number eight the,pri...
Other Biology Technology:FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 2FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 4FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 5FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 6FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 7FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 8FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 9FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes 2Monsanto Recognized as Top Biotechnology Employer by Science Magazine 2
NanoDrop ND-1000 UV-Vis Spectrophotometer from NanoDrop Technologies
Propidium Iodide from Calbiochem
Mouse Anti-Human PUM2 Monoclonal Antibody, Unconjugated, Clone 1C8 from Abnova Corporation
...; Deletion Cosmid Cloning Kit enables you to prepa...mary cosmid library of genomic DNA for subsequent ...fficiency cosmid library construction is accomplis...ls. First, genomic DNA is randomly sheared by pass...
Biology Products: